GHOSH ANIRVAN (Chief Executive Officer) sold 1.4% of their position (1.21K shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $4.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/15/2023ACC: 0000950170-23-028373
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-1.21K
Net shares
Net seller
$4.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.21K disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−1.21K
Price / share
$3.39
Trade value
$4.11K
% of position
1.4%
6/14/2023
87.46K→86.25K
Total
Net shares
−1.21K
Net value
-$4.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 6/14/2023 | S · Sale | −1.21K | $3.39 | $4.11K | 1.4% | 87.46K | 86.25K |
| Total | −1.21K | -$4.11K | ||||||
Derivative Transactions0
No derivative transactions reported